https://www.technologynetworks.com/drug-discovery/news/drug-shows-promise-in-kidney-disease-trial-382155
In a Phase 2 trial of patients with chronic kidney disease, an experimental drug reduced albuminuria – albumin in the urine, a sign of kidney damage.
Create an account or login to join the discussion